The Latest Stem Cell Counting News From Asymmetrex®
Asymmetrex® continues to lead a long-needed reformation in stem cell science and medicine with the development and introducton of innovative biotechnologies for routine, accurate, differential counting of tissue stem cells.
Asymmetrex® Presents the Impact of Differential Stem Cell Counting for Cultured Meat Production
TechCompanyNews Feature Article: Asymmetrex Awarded $1.8M NIH-NHLBI SBIR Phase II Grant To Build Automated Tissue Stem Cell Counter
October 8, 2024 – https://www.techcompanynews.com/asymmetrex-awarded-1-8m-nih-nhlbi-sbir-phase-ii-grant-to-build-automated-tissue-stem-cell-counter/
Asymmetrex Awarded $1.8M NIH-NHLBI SBIR Phase II Grant To Build Automated Tissue Stem Cell Counter
Asymmetrex Awarded $1.8M NIH-NHLBI SBIR Phase II Grant To Build Automated Tissue Stem Cell Counter
Asymmetrex® Awarded $1.8M NIH-NHLBI SBIR Phase II Grant to Manufacture First Differential Tissue Stem Cell Counter
October 2, 2024 – https://www.einpresswire.com/article/747830516
Asymmetrex® Begins New Year with a New Report Demonstrating the Precision of Its Stem Cell Dosing Technology
New Report: Asymmetrex® Stem Cell Counting Technology Used to Confirm Suspected Variability in Stem Cell Preparations
Asymmetrex® Talks with Tech Company News about New Stem Cell Calculators
Asymmetrex® Announces Free Online Calculators for Quantifying Therapeutic Stem Cells
Asymmetrex® Partners to Develop New Mobile App for Stem Cell Science in Indian Livestock and Dairy Industry
Asymmetrex® Publishes First Rating of the Effects of Commercial Growth Factors Used for Stem Cell Biomanufacturing
Asymmetrex® Announces Plan to Develop the First Automated Electronic Cell Counter for Therapeutic Stem Cells
We promise we don’t send spam